Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sight Sciences, Inc. Director's Dealing 2021

Jul 15, 2021

33763_dirs_2021-07-14_33dea384-63a2-48d2-9049-b2d88c6470a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-14

Reporting Person: Offer Andrew (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 129310 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series C Redeemable Convertible Preferred Stock $ Common Stock (3162) Direct
Series A Redeemable Convertible Preferred Stock $ Common Stock (2173912) Indirect
Series B Redeemable Convertible Preferred Stock $ Common Stock (51840) Indirect

Footnotes

F1: The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.